In addition to troponin, B-type natriuretic peptide (BNP) is a well-known serological marker of cardiac dysfunction; however, studies have revealed that BNP levels are inconsistent and thus are not appropriate measurements of cardiomyopathy in DMD patients [181]. The gene discussed is NPPB; the disease is cardiomyopathy.